Back to Browse Journals » Neurobehavioral HIV Medicine » Volume 3

Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS

Authors Singh KK, Nathamu S, Adame A, Alire TU, Dumaop W, Gouaux B, Moore DJ, Masliah E, and HNRC Group

Published Date May 2011 Volume 2011:3 Pages 41—52

DOI http://dx.doi.org/10.2147/NBHIV.S19969

Published 30 May 2011

Kumud K Singh1, Satyanarayana Nathamu1, Anthony Adame2, Tara U Alire1, Wilmar Dumaop2, Ben Gouaux3, David J Moore3, Eliezer Masliah2, and HIV Neurobehavioral Research Center Group
1Department of Pediatrics, 2Department of Neurosciences, 3Department of Psychiatry, University of California San Diego, La Jolla, CA, USA

Abstract: Mannose binding lectin (MBL) activates complement pathway that leads to pathogen opsonization and phagocytosis. MBL deficiency is linked to HIV transmission and disease progression. We sought to determine the role of MBL in HIV encephalitis (HIVE) by evaluating its presence and distribution in the HIV-1-infected brain and by assessing its association with monocyte chemoattractant protein-1 (MCP-1) expression. This retrospective study utilized archived post-mortem brain tissues obtained from 35 individuals enrolled in a longitudinal study as part of the California NeuroAIDS Tissue Network. MBL, MCP-1 and brain cell markers in post-mortem brain tissues with or without HIVE were evaluated using immunocytochemistry, immunofluorescence, confocal microscopy, and western blots. MBL was expressed in neurons, astrocytes, microglia, and oligodendrocytes of the frontal cortex of the HIV-1-infected brain. Overall, there were 30% to 40% more MBL-positive brain cells in HIVE vs non-HIVE cases (P = 0.01, paired t-test). Specifically, there was an increased MBL expression in the neuronal axons of HIVE cases. Also, western blots showed 3- to 4-fold higher levels of 78 kD MBL trimers in HIVE vs non-HIVE cases. This MBL-HIVE link was further confirmed by MBL associated higher MCP-1 expression in HIVE vs non-HIVE cases. HIV negative healthy individuals and normal or the gp120 transgenic mice did not show any differential MBL expression. Increased MBL expression in the major brain cell types, specifically in the neuronal axons of HIVE brain, and MBL associated higher MCP-1 expression in HIVE suggest that MBL could cause neuroinflammation and neuronal injury through MBL complement activation pathway.

Keywords: mannose binding lectin, HIV encephalitis, complement activation, neuroinflammation, neuroAIDS, MCP-1

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Potential and clinical utility of stem cells in cardiovascular disease

Korff Krause, Carsten Schneider, Kai Jaquet, et al

Stem Cells and Cloning: Advances and Applications 2010, 3:49-56

Published Date: 26 March 2010

Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies

Yuan Li, Janine A Burns, Carol A Cheney, et al

Biologics: Targets and Therapy 2010, 4:163-171

Published Date: 15 June 2010

Willingness to participate in a lifestyle intervention program of patients with type 2 diabetes mellitus: a conjoint analysis

van Gils PF, Lambooij MS, Flanderijn MHW, van den Berg M, de Wit GA, Schuit AJ, Struijs JN

Patient Preference and Adherence 2011, 5:537-546

Published Date: 2 November 2011

Objective and subjective in vivo comparison of two emollient products

Djokic-Gallagher J, Rosher P, Walker J, Hart V

Clinical, Cosmetic and Investigational Dermatology 2012, 5:85-91

Published Date: 8 August 2012

Carbon nanotube interaction with extracellular matrix proteins producing scaffolds for tissue engineering

Tonelli FM, Santos AK, Gomes KN, Lorençon E, Guatimosim S, Ladeira LO, Resende RR

International Journal of Nanomedicine 2012, 7:4511-4529

Published Date: 14 August 2012